Mirum Pharmaceuticals Inc (MIRM) — Financial Flexibility Index
Mirum Pharmaceuticals Inc (MIRM) has a Financial Flexibility Index of -0.35x as of March 2026. Free cash flow of $-228.10 Million (operating CF $-228.76 Million minus capex $664.00K) represents 0% of total liabilities ($648.42 Million). Check Mirum Pharmaceuticals Inc investment reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Mirum Pharmaceuticals Inc Financial Flexibility Index (2018–2025)
Historical Financial Flexibility Index trend for Mirum Pharmaceuticals Inc across 8 annual periods. For the full cash flow conversion analysis, see Mirum Pharmaceuticals Inc (MIRM) cash conversion ratio.
Annual Financial Flexibility Index for Mirum Pharmaceuticals Inc (2018–2025)
Year-by-year free cash flow to debt coverage for Mirum Pharmaceuticals Inc. Explore MIRM debt coverage from operations to assess how comfortably operating cash covers total debt obligations.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.11x | $56.78 Million | $55.83 Million | $528.12 Million | ▲ +322.8% |
| 2024 | 0.03x | $11.32 Million | $10.32 Million | $445.11 Million | ▲ +119.9% |
| 2023 | -0.13x | $-50.84 Million | $-70.94 Million | $397.95 Million | ▲ +77.5% |
| 2022 | -0.57x | $-119.86 Million | $-120.14 Million | $210.87 Million | ▲ +12.8% |
| 2021 | -0.65x | $-113.73 Million | $-132.76 Million | $174.44 Million | ▲ +49.5% |
| 2020 | -1.29x | $-88.85 Million | $-89.08 Million | $68.77 Million | ▲ +45.9% |
| 2019 | -2.39x | $-39.08 Million | $-39.36 Million | $16.36 Million | ▼ -2187.7% |
| 2018 | 0.11x | $7.13 Million | $-373.00K | $62.30 Million | — |